SCHEMBL22866748

SCHEMBL22866748

O=C(/C=N/O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CYP1A2 P05177 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GPR35 Q9HC97 1/20 0.50
P2RX1 P51575 7/20 0.49
LMNA P02545 1/20 0.49
ACP1 P24666 1/20 0.47
P2RX4 Q99571 1/20 0.45
P2RX7 Q99572 1/20 0.45
TACR1 P25103 1/20 0.45
TP53 P04637 1/20 0.45
ALDH1A1 P00352 2/20 0.44
JUN P05412 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28937025 1.00 MAPT (0.53) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL8574354 0.84 ALDH1A1 (0.65) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL8574351 0.84 ALDH1A1 (0.65) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL18763049 0.79 TGM2 (0.69) MAPTGPR35P2RX1LMNAACP1
SCHEMBL1398153 0.77 MEN1 (0.68) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL1398151 0.77 MEN1 (0.68) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL9289784 0.77 MEN1 (0.68) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL12835311 0.76 ALDH1A1 (0.72) MAPTMEN1KMT2ANPSR1GPR35
SCHEMBL11442860 0.76 MEN1 (0.57) MAPTMEN1KMT2ACYP1A2NPSR1
SCHEMBL7692960 0.75 GPR35 (0.74) MAPTGPR35P2RX1LMNAACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269756-B 4-Oxo-3, 4-dihydropyrido [3,4-D ] pyrimidine compounds that inhibit EIF4E 效应疗法股份有限公司 2024-05-14 CN disclosed
CN-114269756-A 4-oxo-3, 4-dihydropyrido [3,4-D ] pyrimidine compounds inhibiting EIF4E 效应疗法股份有限公司 2022-04-01 CN disclosed
WO-2021003157-A1 EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS EFFECTOR THERAPEUTICS, INC. (US) 2021-01-07 WO disclosed